MYUNGMOON Pharm co.,Ltd (KRX:017180)
1,690.00
0.00 (0.00%)
At close: Jun 5, 2025, 3:30 PM KST
MYUNGMOON Pharm co.,Ltd Revenue
MYUNGMOON Pharm co.,Ltd had revenue of 45.87B KRW in the quarter ending March 31, 2025, with 3.72% growth. This brings the company's revenue in the last twelve months to 188.09B, up 8.22% year-over-year. In the year 2024, MYUNGMOON Pharm co.,Ltd had annual revenue of 186.44B with 9.95% growth.
Revenue (ttm)
188.09B
Revenue Growth
+8.22%
P/S Ratio
0.30
Revenue / Employee
666.98M
Employees
282
Market Cap
56.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 186.44B | 16.88B | 9.95% |
Dec 31, 2023 | 169.57B | 17.43B | 11.46% |
Dec 31, 2022 | 152.13B | 14.38B | 10.43% |
Dec 31, 2021 | 137.76B | 9.91B | 7.75% |
Dec 31, 2020 | 127.85B | -21.49B | -14.39% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |